RDY NYSE · Healthcare · FY 2026-03-31

DR REDDYS LABORATORIES LTD

Back to NYSE
0.0308.9617.7926.61235.4ABVfair 315.25buy ≤ 173.39EPVfair 891.98buy ≤ 401.39EBVfair 723.81buy ≤ 398.09DBVnot valid for this companyprice 1143.91 INR
0.03.26.49.612.8ABVfair 3.27buy ≤ 1.80EPVfair 9.24buy ≤ 4.16EBVfair 7.50buy ≤ 4.12DBVnot valid for this companyprice 11.85 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in INRUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Franchise
Confidence
●●● High · 3/4
Price
1,143.9111.850 INRUSD *
Market cap
952.52B9.87B INRUSD *
P / B
2.53
P / E
22.25
EPS
51.4200.533
DPS / yield
8.0120.083 (0.7%)
NAV / share
315.253.266
Graham number
723.817.498
Z'' score
6.17
Piotroski F
3 / 9
Beneish M
-2.52
ROIC vs WACC
10.3% vs 6.0%

* Listed in USD — the pipeline states price and all valuations in the filing currency INR (fx 96.53 INR/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.